AASLD The Liver Meeting 2024 The post Brelovitug (BJT-778) Monotherapy Achieved 100% Virologic Response in Patients with Chronic Hepatitis D: On Treatment Week 48 Phase 2 Study Results first appeared on Bluejay Therapeutics .
Need help?
Contact usAASLD The Liver Meeting 2024 The post Brelovitug (BJT-778) Monotherapy Achieved 100% Virologic Response in Patients with Chronic Hepatitis D: On Treatment Week 48 Phase 2 Study Results first appeared on Bluejay Therapeutics .